Blue Horseshoe Stocks: Tech Options Review

OPTIONS REVIEW

We were banking on a market reversal yesterday in tandem with good performances from a couple earnings plays that we formulated some options ideas for, and got everything we wanted.

Both of the plays were in the tech sector, which turned out to see some of the highest incidences of recovery, and it facilitated some very nice gain opportunities for anyone who was paying attention to our ideas.

Despite the appearance of yet another reversal and possibly another down day, we are quite pleased with the double-bag, single-session gains afforded to us by these two tech stocks.

TSLA Weekly $310-317.50 Calls
$275 Calls
– Range: 3.73-8.81 - Max Gain: 136%
$275.50 Calls – Range: 3.10-7.35 – Max Gain: 137%
$276 Calls – Range: 2.41-6.21 - Max Gain: 158%
$276.50 Calls – Range: 2.05-5.04 – Max Gain: 146%
_____

MSFT Weekly $104-107 Calls
$275 Calls
– Range: 2.10-5.40 - Max Gain: 157%
$276 Calls – Range: 2.12-4.45 - Max Gain: 110%
$276 Calls – Range: 1.58-3.58 – Max Gain: 127%
$277 Calls – Range: 1.10-2.75 - Max Gain: 150%

_____

We also had a fresh idea on Wednesday morning with The Boeing Co. BA Weekly $357.50-367.50 Calls and the surge in the markets yesterday also allowed those contracts to get legs and make some very respectable moves:

$275 Calls – Range: 4.00-7.70 - Max Gain: 93%
$275.50 Calls – Range: 2.60-6.00 – Max Gain: 131%
$276 Calls – Range: 1.85-4.32 - Max Gain: 134%
$276.50 Calls – Range: 1.15-2.90 – Max Gain: 152%
$277 Calls – Range: .77-1.85 - Max Gain: 140%
_____

Fresh Ideas:
INTC Weekly $44-45.50 Calls*

*NEVER trade weekly options on a Friday unless you’re an expert level trader with disposable funds!


Extended Watchlist: 
OHGI, NSPR, ATNM, NAUH, GT, PLG, LOGM, TRVN

Blue Horseshoe Stocks: More New Highs on YGYI

Youngevity International Inc. YGYI

We’re coming right back to YGYI for the second straight morning, after the stock once again pushed to new 7-year highs on some of the biggest volume the stock has ever seen.

We slated this play for observation twelve days ago, and its performance across that span has been rather impressive. Our observed low on YGYI of 6.00 has quickly given way to the stock’s new high of 16.20, which represents a gain of 170% in a time frame of less than two weeks.

The stock closed very near to its high of day, and the record volume continues, so with that kind of momentum, we will undoubtedly continue to track its movements as it continues to pierce its way into blue skies.


Fresh Options Ideas

Morgan Stanley MS – In the case of Morgan Stanley, we’re going to come in with an options idea on the heels of the company’s Q3 earnings report. Our target contracts are going to be the MS Weekly $43.50 & $44 Calls.

Ferrari N.V. RACE – Ferrari is simply looking like a technically-sound bottom play at the moment, so we are going to signal some longer term calls here to coincide with a possible upcoming rebound. We’ll radar the RACE 10/26 $120-124 Calls here.


Extended Watchlist: 
SLS, LCI, SEND, CVE, KOOL, NSPR, FLKS

Blue Horseshoe Stocks: Form-4 Plays & More

SPDRA S&P 500 ETF (SPY) – Recap

Our first order of business this morning is to share the performance of the options we alerted on in Friday morning’s report. Those targets were the SPY Weekly $290-291.50 Calls, and they produced some very nice single session gain opportunities for ourselves and our readers.

We have typically been very good playing the SPY in the past, and this time was no different, The gains that were on the table were as follows:

$290 Calls – Range: .34-1.04 – Max Gain: 206%
$290.50 Calls – Range: .12-.58 – Max Gain: 383%
$291 Calls – Range: .20-.46 – Max Gain: 130%
$291.50 Calls – Range: .08-.19 – Max Gain: 138%



Francesca Holdings Corp. FRAN
& Amicus Therapeutics, Inc. FOLD

This morning we noticed that FRAN is exhibiting a number of traits that we normally keep a lookout for. The stock is coming off of a bottom with a large gap on the chart, and on Friday, the CEO filed a Form-4 for the purchase of 10,000 shares near the stock’s lows.

This is often a sign of high internal confidence in the stock’s ability to rebound, so we’re going to place FRAN on recovery watch in the days and weeks ahead.
_____

FOLD is another play which also currently boasts a bottom setup, with a significant amount of insider buying taking place on Thursday at its lows. We’ll definitely want to keep this one on watch as well.


Extended Watchlist:
ACBFF, TLRY, CGC, TPIV, SNES, NSPR

Blue Horseshoe Stocks: AYTU Update & More

Aytu BioScience, Inc. AYTU Yesterday morning, we were just discussing AYTU and the modest progress the stock had made since we flagged it as a bottom play in Wednesday’s premarket report. Not only had it displayed a cherry bottom setup, but we noted a string of insider buysat the time as well.Following that report, we would witness a low of .4118, and over the course of the ensuing four trading days, the stock has made a noteworthy move and continues to exhibit signs that more gains could be in store.

Yesterday it reached .61, which represents a run of 48% in under a week. It did so on record volume, so we’re definitely eager to see where the momentum could carry this play that was already on its way back up.


InspireMD, Inc. NSPR

NSPR has been in real trouble in 2018, losing ground at seemingly every turn and unable to get out of its own way. However, through a combination of a South American breakthrough announcement for two of the companies drugs, and being just plain oversold, we’re seeing a marginal premarket gap-up and will want to observe for a more sustained rebound.

The news was pertaining to NSPR receiving regulatory approval from the goverment of Peru for its CGuard™ Embolic Prevention System (EPS) and MGuard Prime™ products. Peru has a population of more than 30 million people. (>>View PR)


Extended Watchlist:
ARWR, GLOW, MDGS, MBRX, SEE, WBAI, LIQT, PIXY,

Blue Horseshoe Stocks: SVSN Review & More

Stereo Vision Entertainment, Inc. SVSN

It was roughly six weeks back that we put SVSN on our radars on a routine news scan, and as we always say, it’s better to be early to the party than late. All the way up until last week, the stock wasn’t trading with any real vigor, but things have picked in a huge way, both in volume and price.

From its low at .08 at the beginning of last week, the stock finished out at a high of .89, for an intraweek rip of 1012% This came on the news that the company will file a $50M Real Estate Investment Trust on behalf of its CannaVision subsidiary, with the goal of organically growing cannabis for the purposes of extracting CBD.


Progressive Care, Inc. RXMD

We also want to swing back around to RXMD this morning, which we intially tagged onthe morning of February 22nd. Since that time the stock has exhibited a fairly steady climb up the chart.

We observed a low of .0663 in RXMD on that first day, and as of Friday’s new high of .129, we had watched as the stock rose 95% over a period of just seven trading sessions. It’s streaking to its highest PPS in nearly five years, so it’s safe to say RXMD is in blue sky breakout territory, and we’ll be eager to continue tracking its movements.



Fate Therapeutics, Inc. FATE

We also wanted to recap the solid move we’ve witnessed in FATE, since mentioning the stock toward the end of January. It dipped slightly to a low of 6.76 shortly thereafter, and has since gone a very impressive run.

The stock reached a new high of 14.02 on Friday, which worked out to a 108% upswing in a matter of less than a month.


Extended Watchlist:
RJDG, ATNM, INPX, NSPR, GNL, OTIV, CLSD, MYSZ